This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

SILVER SPRING, Md. & ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Maas BiolAB and the Pilot Bioproduction Facility (PBF) of the Walter Reed Army Institute of Research (WRAIR) manufactured Mitogard®, a proprietary cyclosporin formulation. Mitogard® was shown by WRAIR researchers to be neuroprotective in models of traumatic brain injury and seizure-induced brain injury from organophosphate nerve agents. The scale up production of Mitogard® under current good manufacturing practices (cGMPs) is the first drug preparation by the PBF, which previously focused exclusively on vaccines.

This production of Mitogard® was funded by the Ft. Detrick Technology Transfer Initiative (FDTTI) managed by the Maryland Technology Development Corp. (TEDCO). This program supports development of commercial technologies by the private sector to meet the needs of the U.S. Army Medical Research and Materiel Command (USAMRMC). TEDCO works closely with the Frederick County Office of Economic Development and the USAMRMC.

“FDTTI funding advanced the development of cyclosporin neuroprotection,” said Marcus Keep, M.D., CEO of Maas BiolAB. “Our collaboration with WRAIR and the cGMP manufacture at their Pilot Production Facility brings our neuroprotective drug toward the aid of injured soldiers and potential civilian nerve agent casualties.”

About Walter Reed Army Institute of Research

The Walter Reed Army Institute of Research (WRAIR) is the largest and most diverse biomedical research laboratory in the U.S. Department of Defense. For more than 100 years, WRAIR has conducted research on a range of military issues including combat casualty care, and medical defense against biological and chemical weapons to sustain the warfighter. The WRAIR Pilot Production Facility makes vaccines and drugs against biological and chemical threats. (http://wrair-www.army.mil/)

Who is online

This site does not offer, or claim to offer, medical, legal, or professional advice.
All treatment decisions should always be made with the full knowledge of your physicians.
This is MS does not create, endorse, or republish any content.
All postings are the responsibility of the poster. All logos and trademarks in this site are property of their respective owners. All users must respect our rules for intellectual property rights.